Nikki Burdett is a clinician researcher at Peter MacCallum Cancer Centre, focused on improving the lives of individuals with gynaecological cancers. Her research focuses on understanding and manipulating the molecular biology of ovarian cancer to subvert the development of resistance to therapy. She completed her PhD with Dr Liz Christie and Professor David Bowtell, investigating diverse mechanisms of acquired resistance in high grade serous ovarian cancer, and continues to build on these insights in Dr Christie’s laboratory.